drugset / Trial / NCT07097831

A Clinical Trial of HRS-1301 on the Pharmacokinetics of Rosuvastatin Calcium Tablets in Healthy Subjects

NCT07097831

Phase 1 Completed 16 enrolled Shandong Suncadia Medicine Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

The study was designed to evaluate the pharmacokinetic effects of rosuvastatin calcium tablets after oral administration of HRS-1301 in healthy subjects.

Timeline

Start
2025-10-09
Primary completion
2025-11-07
Completion
2025-11-07

Drugs

EvaluationDrugModalityDoseRoute
Subject HRS-1301 Unknown
Subject Rosuvastatin Small molecule

Indications